Form 4 for PED PEDEVCO CORP
Accepted 2025-01-27 00:00:00 ET · period of report 2025-01-23 · accession 0001654954-25-000816 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-01-27 | 2025-01-23+ | PED | Clark Moore | Executive VP | S - Sale | $0.7886 | -175.0K | 1.08M | -14% | -$138.0K |
| T | 2025-01-27 | 2025-01-23 | PED | Clark Moore | Executive VP | A - Grant | $0.00 | +350.0K | 1.21M | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-01-23 | S | D | 50,000 | $0.86 | 855,334 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person to satisfy the Reporting Person's tax liability in connection with the January 23, 2025 vesting of certain shares of restricted stock which were granted under the Company's 2021 Equity Incentive Plan, which grants were exempt from Section 16(b) pursuant to Rule 16b-3. (F2) This transaction was executed in multiple trades at prices ranging from $0.813 to $0.911, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-01-27 | S | D | 125,000 | $0.76 | 1,080,334 | D | — | — | (F5) Shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person to satisfy the Reporting Person's tax liability in connection with the January 25, 2025 and January 26, 2025 vesting of certain shares of restricted stock which were granted under the Company's 2021 Equity Incentive Plan, which grants were exempt from Section 16(b) pursuant to Rule 16b-3. (F6) This transaction was executed in multiple trades at prices ranging from $0.72 to $0.86, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-01-23 | A | A | 350,000 | $0.00 | 1,205,334 | D | — | — | (F3) The shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's 2021 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of (i) 1/3 of the shares on the ten (10) month anniversary of January 23, 2025 (the "Grant Date"); (ii) 1/3 on the twenty-two (22) month anniversary of the Grant Date; and (iii) 1/3 on the thirty-four (34) month anniversary of the Grant Date, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3. (F4) Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as the Executive Vice President, General Counsel and Secretary of the Issuer. |